FLUTICATONE VILO UME
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Fluticasone Furoate, Umeclidinium Bromide & Vilanterol Inhalation Powder
Rs 759.50
MRP Rs 1085.00
(30% OFF)
Includes all taxes
Package SIZE
( for 30 capsules )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
FLUTICATONE VILO UME contains Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate Powder,Helps provide ongoing maintenance treatment for adults aged 18 and above living with COPD or asthma.
Product Information at a Glance
|
Detail |
Information |
|---|---|
|
Brand name |
FLUTICATONE VILO UME |
|
Composition |
Fluticasone Furoate + Umeclidinium Bromide + Vilanterol Trifenatate (inhalation powder) |
|
Strength per capsule |
[Reviewer placeholder – confirm mcg strength of each component from approved label] |
|
Dosage form |
Capsules containing powder for inhalation |
|
Route |
Inhalation only (through the recommended inhaler device) – do not swallow |
|
Pack size |
30 capsules |
|
Therapeutic class |
Triple therapy: inhaled corticosteroid (ICS) + LAMA + LABA |
|
Primary use |
Maintenance treatment of COPD, as prescribed |
|
Marketed by |
Steris Healthcare Pvt. Ltd., India |
|
Schedule |
Prescription only (Schedule H, as per pack label) |
|
Storage |
Cool, dry place in the original pack, protected from moisture and light |
|
Availability |
India |
What Is FLUTICATONE VILO UME?
FLUTICATONE VILO UME is a fixed-dose combination of three inhaled medicines that work on different parts of the breathing problem in COPD. Instead of using three separate inhalers, the person inhales one capsule's worth of powder through a compatible inhaler device, so all three medicines are delivered together, straight to the airways.
The three components are:
- Fluticasone furoate – an inhaled corticosteroid that reduces inflammation (swelling and irritation) inside the airways.
- Umeclidinium bromide – a long-acting muscarinic antagonist (LAMA) that relaxes the muscles around the airways by blocking acetylcholine receptors, helping the airways stay open.
- Vilanterol trifenatate – a long-acting beta-2 agonist (LABA) that relaxes airway muscles by stimulating beta-2 receptors, giving long-lasting bronchodilation.
Because the medicine is inhaled, it acts mainly in the lungs, and much less of it reaches the rest of the body than with tablets or injections of similar drug classes.
Clinical Indications
|
Condition |
Role of this medicine |
Notes |
|---|---|---|
|
COPD (chronic bronchitis and/or emphysema) in adults |
Regular maintenance treatment to ease breathlessness, wheeze and cough and to help lower the chance of flare-ups (exacerbations) |
Usually considered when symptoms or exacerbations continue despite dual therapy; the decision rests with the treating doctor |
|
Asthma in adults |
Only where this specific use appears on the approved product label |
Must be decided and monitored by a doctor; not for self-selection |
|
Sudden breathlessness or an acute attack |
Not indicated |
A fast-acting rescue inhaler prescribed by the doctor must be used instead |
How Does It Work?
COPD narrows the airways through three overlapping problems: inflammation, tightened airway muscles, and mucus. Triple therapy tackles these together.
- Fluticasone furoate calms inflammation. It switches down the inflammatory activity in the airway lining, which can reduce swelling and the tendency to flare up.
- Umeclidinium relaxes airway muscle. By blocking muscarinic receptors, it stops signals that tighten the airway muscle, so air moves more freely.
- Vilanterol adds a second, complementary bronchodilator effect. It acts through beta-2 receptors, a different pathway, so the two bronchodilators work well together.
Key Benefits of Triple Therapy
- Three actions in one device. One inhalation routine replaces multiple inhalers, which can make a treatment plan simpler to follow.
- Targets both airway narrowing and inflammation. Dual bronchodilator action plus an anti-inflammatory component.
- Maintenance control. Designed for steady, regular use to help keep symptoms controlled between flare-ups.
- Fewer devices to manage. Easier to carry, track and teach, particularly for older adults.
- Delivered where it is needed. Inhaled treatment acts directly in the lungs.
- Guideline-recognised option. International COPD guidance, such as the GOLD report, recognises ICS + LAMA + LABA therapy for selected patients, particularly those who continue to have exacerbations or symptoms on dual therapy. [Reviewer placeholder: add exact guideline wording and any clinical statistics only after medical sign-off.]
How to Use the Capsules
The capsules are for inhalation only. Always follow the instructions in the pack leaflet and your doctor's or pharmacist's demonstration for the specific inhaler device supplied or recommended with the pack. [Reviewer placeholder: confirm the compatible device and attach the official device instructions.]
- Wash and dry your hands. Keep the capsule in its blister strip until just before use.
- Load one capsule into the device chamber as shown in the leaflet.
- Prepare the capsule in the device as instructed (for example, by twisting, pressing or piercing, depending on the device).
- Breathe out fully, away from the device.
- Place the mouthpiece in your mouth, close your lips around it and breathe in quickly and deeply.
- Hold your breath for as long as comfortable, then breathe out slowly.
- Check that the capsule is empty. If powder remains, inhale again as the leaflet advises.
- Remove and discard the empty capsule shell, and rinse your mouth with water and spit it out (do not swallow) to help prevent mouth and throat irritation and thrush.
Dosage
- The dose and how often to use it must be set by your doctor and printed on your prescription. [Reviewer placeholder: confirm dosing frequency and maximum daily dose from the approved label.]
- Use it regularly, even on days you feel well, because it is a preventer and not a quick-relief medicine.
- Do not use more than prescribed. Extra doses can increase the risk of heart-related effects such as palpitations.
- If you miss a dose, take the next one at the usual time. Do not double up.
- Keep your doctor-prescribed rescue inhaler with you at all times for sudden symptoms.
- Do not stop suddenly without speaking to your doctor, as symptoms can return or worsen.
Side Effects
Common side effects can include:
- Headache
- Cough, throat irritation, hoarseness or dry mouth
- Oral thrush (white patches in the mouth or throat)
- Cold-like symptoms, nasal congestion or sinus problems
- Sore throat
- Back pain or joint pain
- Constipation
- Urinary tract infection
Serious side effects – seek medical help promptly:
- Sudden worsening of breathing or wheezing right after inhaling (paradoxical bronchospasm)
- Symptoms of pneumonia: increased cough, change in phlegm colour, fever, chills, more breathlessness
- Fast, irregular or pounding heartbeat; chest pain
- Eye pain, blurred vision, halos around lights (possible narrow-angle glaucoma)
- Difficulty or pain when passing urine
- Allergic reaction: rash, swelling of the face, lips or throat
- Very high thirst or frequent urination (possible high blood sugar), or muscle weakness and cramps (possible low potassium)
Precautions and Warnings
Tell your doctor before starting if you have:
- Heart disease, abnormal heart rhythm or high blood pressure
- Narrow-angle glaucoma or increased eye pressure
- Prostate enlargement or difficulty passing urine
- Liver problems
- Diabetes, thyroid problems, low potassium or seizures
- Tuberculosis or any untreated infection
- Allergy to any component or to lactose/milk protein (powder inhalers can contain these) [Reviewer placeholder: confirm excipients]
Important points:
- Not for sudden attacks. It does not give quick relief of acute breathlessness.
- Inhaled steroid effects. Long-term inhaled corticosteroid use can raise the risk of pneumonia in people with COPD and may, rarely, affect bones, eyes and infection resistance. Regular review by your doctor is important.
- Medicines to discuss: other LABA/LAMA inhalers, non-selective beta-blockers, certain antifungals and HIV medicines (strong CYP3A4 inhibitors), diuretics, and antidepressants such as MAOIs or tricyclics. Always share your complete medicine list.
- Pregnancy and breastfeeding: use only if your doctor judges the benefit outweighs the risk.
- Children: not intended for children or adolescents unless specifically prescribed.
- Smoking: stopping smoking is one of the most effective ways to slow COPD. Ask your doctor about support.
How It Compares: Triple vs Dual Inhaled Therapy
|
Option |
Components |
Typically considered when |
|---|---|---|
|
FLUTICATONE VILO UME (ICS + LAMA + LABA) |
Fluticasone furoate + umeclidinium + vilanterol |
COPD symptoms or flare-ups continue despite dual therapy |
|
LAMA + LABA dual therapy |
e.g., umeclidinium + vilanterol |
Persistent breathlessness without a need for an inhaled steroid |
|
ICS + LABA dual therapy |
e.g., fluticasone + salmeterol |
Selected COPD or asthma patients as advised by a doctor |
|
Other ICS + LAMA + LABA triple combinations |
e.g., budesonide + glycopyrronium + formoterol |
Alternative triple therapy; choice depends on device, availability and doctor preference |
Why Choose Steris Healthcare?
Steris Healthcare Pvt. Ltd. is an India-based pharmaceutical manufacturer certified to WHO-GMP and ISO standards, producing prescription and over-the-counter medicines and nutraceuticals for patients, hospitals and distributors across India. Quality systems, batch testing and documentation are central to how our products are made. [Reviewer placeholder: add batch-level quality statements, certificate numbers or licence details only after verification.]
Storage
- Store in a cool, dry place, in the original pack, away from direct sunlight and moisture. [Reviewer placeholder: confirm exact temperature range from label.]
- Keep capsules in the blister until just before use; do not store them inside the device.
- Keep out of reach of children.
- Do not use after the expiry date printed on the pack.
Conclusion
FLUTICATONE VILO UME offers a doctor-directed, once-prepared triple-therapy option for adults with COPD who need anti-inflammatory and dual bronchodilator action together. Used regularly and correctly, with the right inhaler technique and mouth rinsing after each use, it can be an important part of a long-term breathing-care plan. It must be started, reviewed and adjusted by a doctor, and a rescue inhaler should always remain within reach. Prescription only – consult your doctor.
Frequently Asked Questions
1. What is fluticasone furoate, umeclidinium, and vilanterol inhalation powder used for?
It is a three-in-one inhaled maintenance treatment used mainly for COPD in adults. Fluticasone furoate reduces airway inflammation, while umeclidinium and vilanterol are two long-acting bronchodilators that keep the airways relaxed and open. It helps ease breathlessness, wheeze and cough and may help reduce flare-ups. Use in asthma applies only where the approved label includes it and a doctor prescribes it. It is not for sudden attacks.
2. What are the side effects of fluticasone, umeclidinium, vilanterol?
Common effects include headache, cough, sore throat, hoarseness, oral thrush, cold-like symptoms, back or joint pain, constipation and urinary infections. Serious effects need prompt medical attention: worsening wheeze right after a dose, signs of pneumonia, fast or irregular heartbeat, eye pain or blurred vision, trouble passing urine, or an allergic reaction. Rinsing your mouth after each use lowers the risk of thrush.
3. Is fluticasone, umeclidinium, vilanterol a steroid?
It contains one corticosteroid: fluticasone furoate. This is an inhaled corticosteroid that reduces airway inflammation, and it is different from the anabolic steroids used for muscle building. The other two ingredients, umeclidinium and vilanterol, are not steroids; they are bronchodilators. Because the steroid is inhaled, most of the dose stays in the lungs.
4. What are the side effects of powder inhalers?
Dry powder inhalers can cause cough, throat irritation, hoarseness, dry mouth, an unusual taste and, with steroid-containing powders, oral thrush. Some people notice a brief tightening of the chest right after inhaling. Correct technique, mouth rinsing and regular check-ups reduce these problems. Contact your doctor if symptoms persist or breathing worsens after a dose.
5. Are inhalers safe for the lungs?
When prescribed and used correctly, inhalers are considered a safe and effective way to treat lung conditions because they deliver medicine directly to the airways in small doses. The benefits of controlling COPD generally outweigh the risks, since untreated disease can lead to more flare-ups and lung damage. Regular review, correct technique and not exceeding the prescribed dose are key.
6. Can inhalers affect your kidneys?
Inhaled medicines deliver only small amounts into the bloodstream, and these medicines are not known to damage the kidneys at recommended doses. International labelling generally does not require a dose change in kidney impairment for these components. Still, tell your doctor if you have kidney disease, as low potassium and other effects can matter in people with kidney or heart conditions. [Reviewer placeholder: confirm against approved label.]
7. How do I use FLUTICATONE VILO UME capsules?
Place one capsule in the compatible inhaler device, prepare it as per the device leaflet, breathe out, inhale quickly and deeply through the mouthpiece, hold your breath briefly and then rinse your mouth. Use the exact device and technique your doctor or pharmacist has shown you.
8. Can I swallow the capsule?
No. These capsules contain powder meant only for inhalation through the inhaler device. Swallowing a capsule will not treat your lungs. If swallowed by mistake, speak to your doctor or pharmacist.
9. Is FLUTICATONE VILO UME a rescue inhaler?
No. It is a maintenance medicine and does not give quick relief during a sudden attack of breathlessness. Always keep the fast-acting reliever inhaler your doctor prescribed and use it as directed.
10. How long does it take to work?
Some people notice easier breathing within the first days, but the full benefit builds with regular use over weeks. Do not stop because you do not feel an immediate effect, and do not take extra doses.
11. Can I stop using it suddenly?
Please do not stop without speaking to your doctor. Stopping abruptly may let symptoms return or worsen, and your doctor may need to adjust your overall treatment.
12. Do I need to rinse my mouth after using it?
Yes. Rinse your mouth with water and spit it out after every use. This helps remove medicine left in the mouth and lowers the chance of thrush, hoarseness and throat irritation from the inhaled steroid.
13. Can FLUTICATONE VILO UME be used for asthma?
Only if your doctor prescribes it and the approved label of this product includes asthma. Asthma treatment is carefully matched to the individual, so do not use a COPD inhaler for asthma on your own.
14. Is it safe during pregnancy or breastfeeding?
Safety data in pregnancy and breastfeeding is limited. Use only if your doctor decides the benefit outweighs the possible risk, and tell your doctor if you are pregnant, planning pregnancy or breastfeeding.
15. Can it affect the heart?
Long-acting beta-2 agonists such as vilanterol can sometimes cause palpitations, a faster heartbeat or a rise in blood pressure. If you have heart disease or rhythm problems, tell your doctor before starting and report chest pain or irregular heartbeat promptly.
16. Can I use it with other inhalers?
Your doctor may continue a fast-acting reliever inhaler alongside it. Do not add or continue other long-acting bronchodilator (LABA or LAMA) or steroid inhalers unless your doctor specifically advises it, as this can cause an overdose of similar medicines.
17. Do I need a prescription to buy it?
Yes. FLUTICATONE VILO UME is a prescription-only medicine and should be used only under the supervision of a registered medical practitioner.
18. What is the price of FLUTICATONE VILO UME in India?
The price depends on the pack and the MRP printed on it. Use the Check Price contact details in this article, or ask your pharmacist, to confirm the latest price and availability for the pack of 30 capsules. [MRP to be confirmed.]
19. How should I store the capsules?
Keep them in the original blister in a cool, dry place away from sunlight and moisture, and out of reach of children. Remove a capsule only just before use and never store capsules in the inhaler device.
20. Who should not use this medicine?
Do not use it if you are allergic to any ingredient, for relief of a sudden attack, or without a doctor's prescription. People with certain heart, eye, prostate, liver or infection-related conditions need special medical advice before starting.